Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
DMAC
DMAC
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DMAC News
DiaMedica to Present at 2026 Jefferies Global Healthcare Conference
6d ago
Newsfilter
DiaMedica's DM199 Trial Surpasses 75% Enrollment for Interim Analysis
May 20 2026
Newsfilter
DiaMedica Reports Q1 2026 Financial Results and Clinical Updates
May 06 2026
Newsfilter
DiaMedica Therapeutics Stock Shows Oversold Signal
Apr 08 2026
NASDAQ.COM
DiaMedica Therapeutics Q4 2025 Earnings Call Insights
Mar 31 2026
seekingalpha
DiaMedica Therapeutics Reports FY Losses
Mar 30 2026
seekingalpha
Multiple Companies Set to Report Earnings
Mar 30 2026
NASDAQ.COM
DiaMedica to Release Q4 Earnings on March 30
Mar 30 2026
Newsfilter
DiaMedica to Release Full-Year 2025 Financial Results on March 30
Mar 23 2026
Newsfilter
DiaMedica Receives No Objection Letter from Health Canada to Initiate Phase 2 Study for Early-Onset Preeclampsia
Mar 05 2026
Newsfilter
Acute Ischemic Stroke Market Set for Growth Driven by Innovative Therapies
Mar 02 2026
Yahoo Finance
DiaMedica to Participate in Three Investment Conferences
Feb 24 2026
Newsfilter
DiaMedica Therapeutics Grants 50,000 Stock Options to New Employee
Jan 16 2026
Businesswire
DiaMedica Therapeutics Grants 50,000 Stock Options to New Employee
Jan 16 2026
Yahoo Finance
Biotech Surge Post-Market: Inspira, MediciNova, and DiaMedica Therapeutics Among Top Performers
Dec 19 2025
NASDAQ.COM
DiaMedica Engages FDA for DM199 Preclinical Study Clarity
Dec 18 2025
Newsfilter
Show More News
